Skip to content

Nasal Pillows vs. Nasal Masks at High CPAP Pressure

Nasal Pillows at High CPAP Pressure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01690923
Enrollment
20
Registered
2012-09-24
Start date
2011-08-31
Completion date
2012-12-31
Last updated
2014-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OSA

Brief summary

The aim of this evaluation is to test: 1. Whether using nasal pillows at high pressures has comparable outcomes to nasal masks 2. Patient mask type preferences at high pressures

Interventions

Nasal mask (Mirage Activa, Micro, FX)

DEVICEPillows mask

Nasal pillows mask (Swift FX)

Sponsors

ResMed
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients willing to give written informed consent * Patients who can read and comprehend English * Patients being treated for OSA for \>6 months * Patients ≥ 18 years of age * Patients using nasal mask systems with fixed pressure ≥ 12 cm H2O * Patients who can trial the trial masks up to 14 nights * Patients naive to pillows mask systems

Exclusion criteria

* Patients using an inappropriate mask system * Patients using Bilevel flow generators * Patients who are pregnant * Patients who have a pre-existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\< 2years) case of pneumonia or lung infection; lung injury)

Design outcomes

Primary

MeasureTime frameDescription
AHI on Nasal Mask and Pillows Mask7 daysAHI (measure of sleep-disordered breathing severity) on nasal mask and nasal pillows measured as average events/hour

Secondary

MeasureTime frameDescription
UsabilityAfter 7 days of useParticipant's feedback of performance of the study devices. Likert Scale 0-10 (0=very bad, 10=very good)

Countries

Australia

Participant flow

Recruitment details

Participants recruited from ResMed Science Centre, Sydney, between Aug 2011 and Aug 2012

Participants by arm

ArmCount
Current CPAP Users
Nasal mask; Pillows mask Nasal mask : Nasal mask (Mirage Activa, Micro, FX) Pillows mask : Nasal pillows mask (Swift FX)
20
Total20

Baseline characteristics

CharacteristicCurrent CPAP Users
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
12 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
Age, Continuous64.6 years
STANDARD_DEVIATION 9.5
Region of Enrollment
Australia
20 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
15 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

AHI on Nasal Mask and Pillows Mask

AHI (measure of sleep-disordered breathing severity) on nasal mask and nasal pillows measured as average events/hour

Time frame: 7 days

ArmMeasureGroupValue (MEAN)Dispersion
Current CPAP UsersAHI on Nasal Mask and Pillows MaskAHI on nasal mask1.7 events/hourStandard Deviation 1.1
Current CPAP UsersAHI on Nasal Mask and Pillows MaskAHI on Nasal pillows1.9 events/hourStandard Deviation 1.3
Secondary

Usability

Participant's feedback of performance of the study devices. Likert Scale 0-10 (0=very bad, 10=very good)

Time frame: After 7 days of use

ArmMeasureGroupValue (MEDIAN)
Current CPAP UsersUsabilitySubjective Scores Overall Performance-Nasal Mask8.0 Units on a scale
Current CPAP UsersUsabilitySubjective Scores Overall Performance-Nasal Pillow8.5 Units on a scale

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026